爱沙尼亚 -
爱沙尼亚文 -
Ravimiamet
alfacalcidol strides pharma pehmekapsel
strides pharma (cyprus) limited - alfakaltsidool - pehmekapsel - 0,25mcg 100tk; 0,25mcg 50tk; 0,25mcg 90tk
爱沙尼亚 -
爱沙尼亚文 -
Ravimiamet
alfacalcidol strides pharma pehmekapsel
strides pharma (cyprus) limited - alfakaltsidool - pehmekapsel - 0,5mcg 30tk; 0,5mcg 100tk; 0,5mcg 50tk; 0,5mcg 90tk
爱沙尼亚 -
爱沙尼亚文 -
Ravimiamet
combogesic suukaudne suspensioon
swixx biopharma kft. - paratsetamool+ibuprofeen - suukaudne suspensioon - 32mg+9,6mg 1ml 200ml 1tk; 32mg+9,6mg 1ml 100ml 1tk
意大利 -
意大利文 -
Ministero della Salute
aramis plus
globachem nv - 6-benzyladenine; gibberelline (a4+a7); - liquido (senza diluizione) - 1.8 %; 1.8 % i valori indicati sono per 100 g di prodotto. - fitoregolatore
英国 -
英文 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ellaone 30mg tablets
hra pharma uk ltd - ulipristal acetate - tablet - 30mg
欧盟 -
爱沙尼亚文 -
EMA (European Medicines Agency)
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogreel-besilaat - peripheral vascular diseases; stroke; myocardial infarction - antitrombootilised ained - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segmendi elevatsiooniga ägeda müokardi infarkti korral kombinatsioonis asa on meditsiiniliselt ravitud patsientide abikõlblikud trombolüütiline ravi. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. täiendava teabe jaoks vt osa 5.